What Are Endocannabinoids?
Endocannabinoids are lipid-based signaling molecules synthesized "on demand" from membrane lipids in response to neural activity, serving as retrograde messengers that regulate neurotransmitter release and maintain homeostasis across multiple physiological systems. 1
Core Components of the Endocannabinoid System
The endocannabinoid system (ECS) comprises three essential elements discovered in the early 1990s through research on Δ9-tetrahydrocannabinol (THC): 1
- Primary endocannabinoids: Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are the two most thoroughly studied endogenous cannabinoids 1, 2
- Cannabinoid receptors: CB1 and CB2 receptors, which are G-protein-coupled receptors 1
- Metabolic enzymes: Including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), ABHD4, COX-2, and LOX that synthesize and degrade endocannabinoids 1
Unique Signaling Mechanism
Unlike classical neurotransmitters, endocannabinoids function as retrograde messengers—they travel backward across synapses from the postsynaptic neuron to the presynaptic terminal. 1 This distinctive mechanism allows them to:
- Modulate both excitatory and inhibitory neurotransmission 1
- Regulate neurotransmitter release in a feedback manner 1
- Contribute to synaptic homeostasis and plasticity 1
The synthesis occurs "on demand" directly from membrane phospholipids in response to increased intracellular calcium or activation of specific receptors, rather than being stored in vesicles like traditional neurotransmitters. 1
Receptor Distribution and Function
CB1 Receptors
CB1 receptors are predominantly expressed in the central nervous system, particularly in brain regions controlling cognition, emotion, and motor function. 1 Key locations include:
- Hippocampus (memory and learning) 1
- Amygdala (emotional processing) 1
- Prefrontal cortex (executive function) 1
- Basal ganglia (motor control) 1
- Hypothalamus (homeostatic regulation) 1
CB2 Receptors
CB2 receptors are primarily associated with peripheral immune cells but become upregulated in the brain under pathological conditions, suggesting involvement in neuroinflammation. 1
Physiological Roles
The ECS participates in a broad array of functions: 1
- Neurogenesis and neuroprotection 1
- Immune modulation 1
- Pain perception 1
- Energy balance and metabolism 1
- Gut-brain axis homeostasis 1
- Circadian rhythm regulation via CB1-mediated effects on the suprachiasmatic nucleus, influencing sleep-wake cycles 1
Clinical Significance
Psychiatric and Neurological Conditions
ECS dysregulation has been implicated in multiple disease states: 1
- Depression and anxiety 1
- Schizophrenia 1
- Post-traumatic stress disorder (PTSD) 1
- Addiction 1
- Neurodegenerative diseases 1
Depression-Specific Mechanisms
CB1 receptor activation promotes hippocampal neurogenesis and enhances synaptic plasticity through upregulation of brain-derived neurotrophic factor (BDNF). 1 The absence of CB1 receptors has been associated with depressive-like behaviors, highlighting their neuroprotective role. 1
Important Clinical Caveats
Chronic cannabis use, especially in adolescents and young adults, has been associated with heightened risk of psychosis and schizophrenia, demonstrating complex, dose- and age-dependent effects of exogenous cannabinoid exposure. 1 This underscores that while the endogenous system serves protective functions, excessive exogenous cannabinoid exposure—particularly during neurodevelopment—can produce harmful outcomes.
The therapeutic window for cannabinoid-based interventions requires careful consideration of: